The Role of LAPTM4B in Hepatocellular Carcinoma Stem Cell Proliferation and MDSC Migration: Impact on HCC Progression and Response to...
FDA Approves First Cell Therapy for Solid Tumors, Marking a Significant Milestone In a groundbreaking development, the U.S. Food and...
Repotrectinib, a promising targeted therapy, has shown significant tumor reduction in patients with ROS1-positive non-small cell lung cancer (NSCLC). This...
Using Microrobots Controlled by a Magnetic Field for the Treatment of Liver Cancer Liver cancer is a serious and potentially...
Potential for cancer treatment demonstrated by metal-free graphene quantum dots Graphene, a two-dimensional material made up of a single layer...
Exploring the Latest Discoveries: Cool Olfactory Tuft Cells, T-Cell Therapy, and NK Cells in The Niche The field of medical...
Inhalable Nanosensors: Revolutionizing Lung Cancer Screening Accessibility Lung cancer is one of the leading causes of cancer-related deaths worldwide, with...
Ezra, a New York-based medical imaging company, has recently secured $21 million in funding to further develop their AI-powered full...
Separating Fact from Fiction: Understanding Exosomes in Regenexx’s Sales Pitch In recent years, there has been a surge of interest...
Immunotherapy Drug Makes Groundbreaking Progress in First Trial in Fifty Years In a significant breakthrough for cancer treatment, a new...
Gilead Sciences, a leading biopharmaceutical company, has recently announced its plans to expand its investment in Arcus Biosciences and its...
Title: The Potential of an Immunological Trojan Horse for Disease Treatment Introduction: In recent years, scientists have been exploring innovative...
An Overview of Genentech’s i-shaped Abs: A Bispecific Dendritic-T Cell Engager and Beyond Genentech, a leading biotechnology company, has been...
Nanoform, a leading nanoparticle medicine enabling company, has recently reported promising clinical results for patient-centric nanotechnology-enhanced enzalutamide. Enzalutamide is a...
Aulos Bioscience, a leading biotechnology company, has recently announced the administration of the first dose to a patient in the...
